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Objectives: To assess the outcome of surgical treatment for severe bilateral renal artery stenosis. 
Design: Non-randomised, prospective, consecutive series. 
Materials: Twenty-five patients undergoing surgical reconstruction of whom 14 required aortic replacement (aneurysm, 
n = 7, severe claudication, n = 7). In 22 patients, the principle aim of treatment was preservation or salvage of renal 
function whilst three patients had intractable hypertension. 
Methods: Serum creatinine and blood pressure were measured at the most recent follow-up (minimum 6 months, median 
17 months) and compared to preoperative values. 
Results: Renal function (serum creatinine) improved or stabilised in 16 of 18 patients in whom it was elevated 
preoperatively (> 140/~mol/l; 3 patients on dialysis) whilst one patient with early graft occlusion subsequently required 
long term dialysis. Blood pressure control was also improved in 14 patients. There were four postoperative deaths (16%) 
and five patients required re-exploration for postoperative anuria (3) or bleeding (2). 
Conclusions: Surgical revascularisation preserves renal function and may improve blood pressure control in patients with 
advanced multi-system atherosclerosis. The operative morbidity and mortality is significant although historical data 
suggests that this is less than for similar patients treated medically. 
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Introduction 
Renal artery atherosclerosis is progressive, and may 
culminate in the development of a critical stenosis or 
occlusion of the affected artery. Patients with bilateral 
disease have a high risk of a significant reduction in 
renal function and it has been estimated that 16.5% of 
dialysis patients have uncorrected renovascular dis- 
ease) These patients have a particularly poor prog- 
nosis with an annual mortality of 20-30%. 1Previous 
reports have indicated that renal revascularisation can 
improve or stabilise renal function in some patients 
with ischaemic renal disease 2-4 and that improved 
renal perfusion may result in more effective control of 
associated hypertension. 2'3Furthermore, Hunt et al. s 
compared the results of medical or surgical manage- 
ment in two similar groups of patients with renovas- 
cular hypertension and reported that surgical revascu- 
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larisation was associated with a reduction in both 
morbidity (stroke, myocardial infarction) and 
mortality. 
Many of the previous reports describing the results 
of surgical treatment for renal artery stenosis have 
concentrated upon patients with unilateral disease. In 
contrast his paper describes the results of surgical 
reconstruction i  a consecutive series of patients with 
severe bilateral renal artery atherosclerosis, the major- 
ity of whom showed evidence of multisystem arterio- 
sclerosis. Percutaneous renal artery angioplasty had 
either failed or was considered inappropriate for these 
patients. 
Patients and Methods 
Between June 1990 and September 1994, 25 patients 
(11 male, 14 female; mean age 67 (52--79) years) 
underwent surgery for bilateral atherosclerotic reno- 
vascular disease. Selection of patients for surgery was 
based upon the results of investigation by the ~efer- 
ring nephrologist or cardiologist in conjunction with a 
vascular adiologist. Percutaneous transluminal renal 
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Table 1. Presence of symptomatic extra-renal vascular disease 
No (%) 
Aortoiliac atherosderosis 14 (56) 
Aortic aneurysm 7 (23) 
Coronary artery disease 5 (21) 
Infrainguinal occlusive disease 6 (25) 
Cerebrovascular disease 4 (17) . 
angioplasty (PTRA) was attempted in one patient but 
had been unsuccessful. In the remainder the radi- 
ologist felt that PTRA was inappropriate because of 
extensive ostial atherosclerosis which was associated 
with severe aortic disease in 17 patients. No patient 
was rejected for surgery and all renal arteries had 
stenoses between 70-100% (i.e. occlusion). In 22/25 
(84%) patients, with an elevated serum creatinine 
(> 140 vmol/1), the primary indication for surgery 
was impaired renal function and three patients 
required preoperative dialysis (duration 2--7 days) for 
acute renal failure. The remaining three patients were 
referred for surgery on the basis of intractable hyper- 
tension although all patients in this series were 
hypertensive and the majority required multiple drug 
therapy. Six patients had required previous hospital 
admission for cardiac failure. 
Prior to operation all patients underwent digital bi- 
planar arteriography and renal ultrasonography. In
16/25 patients there was occlusion of one renal artery 
with a > 70% stenosis of the contralateral renal artery. 
None of the angiograms demonstrated filling of a 
patent distal renal artery via collateral vessels when 
the main renal artery was occluded, and all such 
kidneys measured < 8cm in length on ultrasonog- 
raphy. Similarly three further patients had bilateral 
stenoses in patent renal arteries but with one non- 
functioning kidney which was < 8 cm in inter-polar 
length. Thus 19/25 patients underwent unilateral 
renal revascularisation, of whom 10, with particularly 
severe hypertension, underwent contralateral, 
nephrectomy in an attempt to achieve maximum 
blood pressure control. 
The remaining six patients had bilateral renal artery 
stenoses of > 70% In all patients the smallest kidney 
measured > 8 cm in length and thus bilateral recon- 
struction was performed. No patient in this series had 
undergone previous renal surgery or nephrectomy. 
Of 17 patients with severe co-existing aortic disease 
was present 20 patients (80%), 14 of whom required 
aortic replacement either for an aortic aneurysm 
> 6 cm diameter (n = 7) or severe symptomatic occlu- 
sive disease (n = 7). Whilst the majority of patients 
also had symptomatic evidence of vascular disease 
elsewhere (Table 1) no specific investigations were 
Table 2. Surgical procedures in patients undergoing surgery for 
bilateral renal artery atherosclerosis 




Inverted acron Y graft 
(bilateral) 
Autogenous artery: unilateral 
16 Aortic graft 12 
4 Aorta 8 
2 Aortic graft 2 
3 Gastroduodenal 2 
Splenic artery 1 
• 10 of these patients underwent contralateral nephrectomy. 
undertaken to ascertain the presence of asymptomatic 
coronary or carotid disease. The surgical procedures 
performed are listed in Table 2. 
Following discharge regular assessments of renal 
function and blood pressure were made. According to 
the criteria of Weibull et al. 6 a > 15% reduction in 
serum creatinine at the most recent follow-up was 
assumed to represent a significant improvement in 
renal function whilst a >15% increase indicated 
deteriorating renal function. Renal function was con- 
sidered stable or unchanged when serum creatinine 
remained within these ranges. 
Similarly renovascular hypertension was consid- 
ered to have resolved in patients with a diastolic blood 
pressure of 90 mm Hg or less requiring no medication, 
or to have improved if one of the following occurred: 
(1) distolic blood pressure 91-109mm Hg and a 
decrease of 15% or more compared to the preoperative 
level; (2) diastolic blood pressure 91-109mm Hg, a 
decrease of 10% (vs. preoperative) and discontinuation 
of at least one anti-hypertensive agent; (3) distolic 
blood pressure 90 mm Hg or less and discontinuation 
of at least one drug. 7 
Comparative analyses of serum creatinine values 
were undertaken using the Wilcoxon test. The median 
duration of follow-up is 17 months (range 6--35 
months). 
Results 
Four deaths occurred within 30 days of surgery, an 
operative mortality of 16%. The cause of death was 
myocardial infarction (3) and postoperative haemor- 
rhage complicated by multi-organ failure (1). Sig- 
nificantly there have been no deaths during follow-up. 
There were four non-fatal complications (myocardial 
infarction (1), mild CVA (1), abdominal wound dehis- 
cence (1), perforated sigmoid diverticulum (1). Three 
patients underwent early relaparotomy for post- 
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Table 3. Effect of renal revascularisation upon serum creatinine 
Serum creatinine (/zmol/1) Patient 
No. Preoperative Discharge Latest follow-up Follow-up 
1 540 343 264 2yr7months  
2 163 91 115 l y r l0months  
3 Dialysis 145 192 l yr3months 
4 Dialysis 150 115 l yr3months 
5 156 125 125 8months 
6 251 237 172 2yr8months  
7 104 75 65 9months 
8 Dialysis 184 143 2yr  
9 197 205 222 2yr l lmonths  
10 520 575 480 7months 
11 95 93 97 8months 
12 266 340 283 2y  r5 months 
13 155 132 149 9months 
14 158 153 138 l yr7months 
15 225 200 208 1yr l lmonths  
16 197 193 175 l yr5months 
17 172 152 145 7rnonths 
18 164 171 223 2yr6months  
19 104 134 146 l yr 
20 441 203 183 6months 
21 163 Dialysis Dialysis 9months 
operative anuria and the renal graft was occluded in 
two. Following revision, one patient recovered normal 
renal function whilst the other has required long term 
dialysis. In the third anuric patient both renal grafts 
were patent and following a short period of post- 
operative dialysis (1 week) renal function recovered 
and has remained stable for 17 months. 
Surgical re-exploration for suspected bleeding was 
undertaken i  two patients. One patient, who devel- 
oped DIC, subsequently died from multi-organ failure 
whilst the other recovered uneventfully. Three of the 
four deaths occurred in the 14 patients undergoing 
simultaneous aortic replacement. 
The effect of revascularisation upon renal function 
in the 21 patients discharged from hospital is shown in 
Table 3 and Fig. 1. In these patients the median serum 
creatinine levels were: preoperativel~ 185~mol/1 
(range 95-883); discharge, 173 btmol/1 (range 91-637); 
latest follow-up, 163 btmol/1 (range 65-616). Although 
these reductions were not statistically significant, nine 
patients have achieved a > 15% reduction in serum 
creatinine and in nine renal function has remained 
stable. All patients requiring preoperative haemodial- 
ysis now have normal renal function. Whilst three 
patients experienced a deterioration i renal function 
this was not clinically important in two (most recent 
serum creatinine 146 btmol/1, 223 ~tmol/1) although the 
third (immediate graft failure) continues to require 
dialysis. No patient has developed renal failure since 
discharge and thus renal function has been preserved 
in 20/21 patients. 
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Fig. 1. Effects of renal revascularisation serum creatinine. 
Table 4. The effect of renal revascularisation upon blood pressure 
(BP) control 
Patient No. of No. of 
no. Preoperative drugs Latest BP drugs 
1 180/100 5 
2 210/100 3 
3 200/115 4 
4 130/90 3 
5 160/100 3 
6 215/120 3 
7 240/110 3 
8 230/130 4 
9 240/140 0 
10 200/90 2 
11 170/100 4 
12 200/100 2 
13 140/80 2 
14 130/80 3 
15 250/130 4 
16 200/110 4 
17 220/100 4 
18 160/100 3 
19 110/60 2 
20 160/90 2 






















Table 4. Revascularisation reduced the median dia- 
stolic blood pressure from 100 rnm Hg (range 60-140) 
preoperatively to 90 mm Hg (range 70-100) at follow- 
up. The number of anti-hypertensive drugs required 
to control blood pressure was reduced from a median 
of three per patient (range 0-5) to two per patient 
(range 1-4). No patient was cured of hypertension but 
control was improved in 17/21 patients. In four 
patients the severity of hypertension or the number of 
anti-hypertensive drugs required for its control was 
unaffected by surgery. 
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Discussion 
Whilst the risk of a renal artery stenosis progressing to 
occlusion is variously reported as 11% at 2 years for 
lesions of > 60% 8 or 40% at I year for > 75% stenoses 9 
it appears that the risks of renal failure or death are 
particularly high when the disease is bilateral. Thus 
Connolly et al. o have reported 2 year actuarial renal 
survival rates of 82% for patients with bilateral renal 
artery stenoses, and 45% for those with a unilateral 
occlusion and contralateral stenosis. Mortality rates in 
these groups were 26% and 53% respectively at 2 
years. Similarly 16.5% of a chronic dialysis population, 
of similar age to the patients in the present studN have 
uncorrected renovascular disease. These patients have 
a particularly poor prognosis with a median survival 
of 27 months and a 5 year survival of only 
12% ]Although there have been no prospective studies 
comparing the efficacy of medical and surgical treat- 
ment for patients with advanced renal artery athero- 
sclerosis there are a number of reports uggesting that 
surgical revascularisation may improve or stabilise 
renal function. 2-4 Similarly a beneficial reduction in 
blood pressure reduces the risk of hypertensive 
nephrosclerosis 2"3and other complications of uncon- 
trolled hypertension. Thus patients who have under- 
gone renal revascularisation appear to have a lower 
morbidity and mortality than those treated 
medically. 5 
This report focuses upon patients with either 
bilateral high grade renal artery stenoses or a uni- 
lateral stenosis associated with a contralateral renal 
artery occlusion. These patients require special con- 
sideration since they have a high risk of developing 
renal failure. 11'12 The majority of patients with this 
pattern of renovascular disease have symptomatic 
arteriosclerosis at other sites and thus their manage- 
ment must be considered carefully. If it is accepted 
that revascularisation is the most appropriate therapy 
then a choice must be made between surgery or 
PTRA. 
PTRA has obvious attractions in view of its low 
morbidity and mortality 9 although its efficacy has 
generally been described in patients with unilateral 
renal artery stenosis. Thus Weibull et al. have reported 
primary patency rates of 75% for such patients with 
83% of the study group avoiding surgical reconstruc- 
tion. 13 In other reports restenosis rates following 
PTRA of ostial stenoses vary between 15-35%. 14'~5 
However a recent report by Bird et al. 16 in 19 patients 
who were remarkably similar to those included in the 
present study indicated that renal function was 
improved in only eight patients whilst three patients 
died following urgent surgical reconstruction for 
complications of PTRA. The authors conclude that 
planned surgical reconstruction should be the primary 
procedure of choice in patients with severe bilateral 
atherosclerotic renovascular disease. Similarly, Patty- 
nama et aI. have reported that 40% of azotaemic 
patients undergoing PTRA experienced a further 
deterioration i  renal function by 1 year. 17 Thus the 
role for PTRA in patients with several bilateral renal 
artery stenosis and impaired renal function has not 
been clearly established, particularly in the presence 
of co-existing aortic disease. It is possible however 
that intravascular stenting may increase the success of 
PTRA in the future although the results of long term 
follow-up for such patients is awaited. In our patients 
PTRA had failed in one patient and the remainder 
were considered unsuitable for this procedure by a 
vascular adiologist. 
The surgical procedure mployed was largely dic- 
tated by the severity and nature of co-existing aortic 
disease. Aortic replacement was performed in 14 
patients with either an aortic aneurysm or severe, 
symptomatic aortoiliac disease. There were three 
deaths in this subgroup which is similar to the 
mortality from other centres. 2'3'12 In contrast those 
series which report the lowest morbidity and mortal- 
ity for renal revascularisation rarely include this type 
of patient. 4'1~ Extra-anatomical renal bypass using the 
hepatic or splenic arteries has been recommended 
when the aorta is atherosclerotic but does not require 
replacement 4'19 and this was performed in three 
patients. The remaining eight patients underwent 
aortorenal revascularisation using autologous aphe- 
nous vein, a method which has been shown to 
produce excellent long term results. 12 
Nineteen of our patients had a single functioning 
kidney, of whom 16 had a unilateral high grade 
stenosis with occlusion of the contralateral renal 
artery. It has been suggested that revascularisation f a 
kidney supplied by an occluded renal artery may be 
possible if angiography confirms filling of a patent 
distal vessel via collaterals. 11In such circumstances 
useful recovery of renal function may occur, partic- 
ularly if the kidney is > 9cm in length on ultrasound, n 
Neither of these features applied to any of our patients 
with an occluded renal artery and thus nephrectomy 
was performed in 10 patients with the aim of 
improving blood pressure control and avoiding the 
detrimental effects of uncontrolled hypertension upon 
the revascularised kidney. 2° 
The effect of surgery upon renal function has been 
encouraging. Of 13 patients followed-up for > 1 year 
all are alive and none dependent upon dialysis. 
Similarly, whilst four patients were considered to have 
malignant hypertension preoperatively with a dia- 
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stolic blood pressure of up to 140mm Hg the 
maximum diastolic pressure at follow-up was 100 mm 
Hg. Although follow-up angiograms were not per- 
formed in these patients 16/21 patients who were 
discharged from hospital had a single functioning 
kidney and thus patency of the graft can be assumed 
as judged by the satisfactory outcome• 
The beneficial effects of surgery upon renal function 
and hypertension must be weighed against the risks of 
death or morbidity following surgery• In this series the 
overall mortality was 16% (4 patients)• Three of the 
four deaths occurred in patients with symptomatic 
coronary artery disease following a myocardial infarc- 
tion. It has been suggested that such patients hould 
undergo preoperative coronary angiography and 
• • 18 bypass prior to renal revasculansatlon and such a 
policy is perhaps worthy of consideration i selected 
patients. 
Improved pharmacological therapy and the devel- 
opment of PTRA has resulted in the majority of 
patients with renovascular hypertension being man- 
aged non-surgically. As a result most of the patients 
who are currently referred for surgical treatment have 
advanced generalised atherosclerosis in whom preser- 
vation of renal function is the main indication for 
intervention• There have been no prospective trials of 
surgery and medical therapy for this group of patients 
although in the presence of severe bilateral renal 
artery disease it seems logical to suggest that revascu- 
larisation should be considered• The risks of con- 
servative therapy are high and have been discussed 
earlier. 
In summary this study has shown that surgical 
treatment ofpatients with bilateral renal artery athero- 
sclerosis improves both renal function and blood 
pressure control in the majority of patients. However 
the risks of surgery are considerable and the decision 
to operate must be carefully considered in each 
patient. Surgery is clearly justified in those patients 
who require preoperative dialysis or those in whom 
renal function is rapidly deteriorating. However in 
patients with acceptable renal function and blood 
pressure, but with angiographic evidence of sig- 
nificant renal artery disease, then careful monitoring 
during an initial trial of conservative treatment may be 
more appropriate• The presence of co-existing aortic 
disease is also a cause for concern in view of the 
higher operative mortality associated with combined 
procedures• For these patients revascularisation using 
the splenic or hepatic arteries is the treatment ofchoice 
utlless aortic replacement is unavoidable. The risks 
and benefits of renal revascularisation are difficult to 
predict and the optimum management for an individ- 
ual can only be decided after careful assessment by 
both the referring nephrologist or cardiologist and the 
surgeon. 
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